These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28762689)
21. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five? Kumarasinghe SP; Kumarasinghe MP Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583 [No Abstract] [Full Text] [Related]
23. Leprosy in Nonimmigrant Canadian Man without Travel outside North America, 2014. Bonnar PE; Cunningham NP; Boggild AK; Walsh NM; Sharma R; Davis IRC Emerg Infect Dis; 2018 Jan; 24(1):165-166. PubMed ID: 29260666 [TBL] [Abstract][Full Text] [Related]
24. Lepromatous Leprosy with Crusted Scabies. Ashraf R; Narang T; Kumaran MS Am J Trop Med Hyg; 2020 Dec; 103(6):2158-2159. PubMed ID: 33269674 [No Abstract] [Full Text] [Related]
25. Multidrug therapy regimen for leprosy. Firooz A J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233 [No Abstract] [Full Text] [Related]
26. Leprosy. Indian J Med Sci; 1997 Dec; 51(12):482. PubMed ID: 9715550 [No Abstract] [Full Text] [Related]
27. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year. Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy. Languillon J; Yawalkar SJ; McDougall AC Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454 [No Abstract] [Full Text] [Related]
29. [What is your diagnosis? Sensory motor polyneuropathy in borderline leprosy. Trophic skin disorders with ulcerations, local superinfection on the right foot with right inguinal lymphadenopathy]. Siccoli M; Bassetti C Praxis (Bern 1994); 2002 Jan; 91(3):49-52. PubMed ID: 11845612 [No Abstract] [Full Text] [Related]
30. The future of leprosy in the Dominican Republic: experience with multidrug therapy. Martinez Cruz D Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953 [No Abstract] [Full Text] [Related]
34. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases. Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089 [TBL] [Abstract][Full Text] [Related]
35. Multiple livid-erythematous macules and plaques with slight scaling in a young man. Müller A; Wolfsperger F; Kofler L; Yazdi AS J Dtsch Dermatol Ges; 2018 Oct; 16(10):1282-1285. PubMed ID: 30248227 [No Abstract] [Full Text] [Related]
36. Evaluation of drug regimen in lepromatous leprosy--II. Ramu G; Sreevatsa Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452 [TBL] [Abstract][Full Text] [Related]
37. Dapsone syndrome with acute renal failure during leprosy treatment: case report. Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852 [TBL] [Abstract][Full Text] [Related]
38. Why multidrug therapy for multibacillary leprosy can be shortened to 12 months. Ji B Lepr Rev; 1998 Jun; 69(2):106-9. PubMed ID: 9715593 [No Abstract] [Full Text] [Related]